Plasma Kynurenine-to-Tryptophan Ratio, a Highly Sensitive Blood-Based Diagnostic Tool for Tuberculosis in Pregnant Women Living With Human Immunodeficiency Virus (HIV).
IDO
Target product profile
kynurenine/tryptophan ratio
sensitivity
specificity
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
15 09 2021
15 09 2021
Historique:
received:
19
12
2020
pubmed:
16
3
2021
medline:
8
10
2021
entrez:
15
3
2021
Statut:
ppublish
Résumé
For pregnant women living with human immunodeficiency virus (HIV), concurrent active tuberculosis (TB) disease increases the risk of maternal mortality and poor pregnancy outcomes. Plasma indoleamine 2,3-dioxygenase (IDO) activity measured by kynurenine-to-tryptophan (K/T) ratio has been proposed as a blood-based TB biomarker. We investigated whether plasma K/T ratio could be used to diagnose active TB among pregnant women with HIV. Using an enzyme-linked immunosorbent assay (ELISA), we measured K/T ratio in 72 pregnant women with and active TB and compared them to 117 pregnant women with HIB but without TB, matched by age and gestational age. Plasma K/T ratio was significantly elevated during pregnancy compared to sampling done after pregnancy (P < .0001). Pregnant women who had received isoniazid preventive therapy (IPT) before enrollment had decreased plasma K/T ratio compared to those who had not received IPT (P = .0174). Plasma K/T ratio was elevated in women with active TB at time of diagnosis compared to those without TB (P < .0001). Using a cutoff of 0.100, plasma K/T ratio gave a diagnostic sensitivity of 94% (95% confidence interval [CI]: 82-95), specificity of 90% (95% CI: 80-91), positive predictive value (PPV) 85% and negative predictive value (NPV) 98%. A receiver operating characteristic curve (ROC) gave an area under the curve of 0.95 (95% CI: .92-.97, P < .0001).In conclusion, plasma K/T ratio is a sensitive blood-based diagnostic test for active TB disease in pregnant women living with HIV. Plasma K/T ratio should be further evaluated as an initial TB diagnostic test to determine its impact on patient care.
Sections du résumé
BACKGROUND
For pregnant women living with human immunodeficiency virus (HIV), concurrent active tuberculosis (TB) disease increases the risk of maternal mortality and poor pregnancy outcomes. Plasma indoleamine 2,3-dioxygenase (IDO) activity measured by kynurenine-to-tryptophan (K/T) ratio has been proposed as a blood-based TB biomarker. We investigated whether plasma K/T ratio could be used to diagnose active TB among pregnant women with HIV.
METHODS
Using an enzyme-linked immunosorbent assay (ELISA), we measured K/T ratio in 72 pregnant women with and active TB and compared them to 117 pregnant women with HIB but without TB, matched by age and gestational age.
RESULTS
Plasma K/T ratio was significantly elevated during pregnancy compared to sampling done after pregnancy (P < .0001). Pregnant women who had received isoniazid preventive therapy (IPT) before enrollment had decreased plasma K/T ratio compared to those who had not received IPT (P = .0174). Plasma K/T ratio was elevated in women with active TB at time of diagnosis compared to those without TB (P < .0001). Using a cutoff of 0.100, plasma K/T ratio gave a diagnostic sensitivity of 94% (95% confidence interval [CI]: 82-95), specificity of 90% (95% CI: 80-91), positive predictive value (PPV) 85% and negative predictive value (NPV) 98%. A receiver operating characteristic curve (ROC) gave an area under the curve of 0.95 (95% CI: .92-.97, P < .0001).In conclusion, plasma K/T ratio is a sensitive blood-based diagnostic test for active TB disease in pregnant women living with HIV. Plasma K/T ratio should be further evaluated as an initial TB diagnostic test to determine its impact on patient care.
Identifiants
pubmed: 33718949
pii: 6170938
doi: 10.1093/cid/ciab232
pmc: PMC8442800
doi:
Substances chimiques
Kynurenine
343-65-7
Tryptophan
8DUH1N11BX
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1027-1036Subventions
Organisme : NICHD NIH HHS
ID : R01 HD064354
Pays : United States
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.
Références
Clin Infect Dis. 2017 Oct 15;65(8):1356-1358
pubmed: 29017244
Sci Rep. 2016 Jan 27;6:19916
pubmed: 26814137
Front Immunol. 2017 Oct 27;8:1360
pubmed: 29163470
Front Cell Infect Microbiol. 2019 Oct 29;9:372
pubmed: 31737575
Infect Drug Resist. 2019 May 14;12:1265-1276
pubmed: 31190914
Clin Infect Dis. 2019 Apr 8;68(8):1274-1281
pubmed: 30107503
Clin Infect Dis. 2018 Mar 5;66(6):921-929
pubmed: 29028970
Nat Rev Neurosci. 2008 Jan;9(1):46-56
pubmed: 18073775
Clin Infect Dis. 2003 Feb 15;36(4):453-60
pubmed: 12567303
Lancet Infect Dis. 2009 Mar;9(3):173-84
pubmed: 19246021
Am J Reprod Immunol. 2018 Apr;79(4):e12786
pubmed: 29154462
Science. 1998 Aug 21;281(5380):1191-3
pubmed: 9712583
Biochem J. 1985 Sep 15;230(3):635-8
pubmed: 3877502
PLoS One. 2013 Apr 17;8(4):e62211
pubmed: 23614037
Int J Infect Dis. 2020 Oct;99:441-448
pubmed: 32800860
Obstet Gynecol. 2009 Aug;114(2 Pt 1):292-299
pubmed: 19622990
J Immunol. 2009 Jul 1;183(1):718-31
pubmed: 19535630
Immunol Rev. 2008 Apr;222:206-21
pubmed: 18364004
Front Immunol. 2014 Oct 20;5:521
pubmed: 25368620
Int J Tuberc Lung Dis. 2004 Jan;8(1):59-69
pubmed: 14974747
Int J Infect Dis. 2015 Mar;32:124-7
pubmed: 25809768
Am J Respir Crit Care Med. 2012 Apr 1;185(7):779-84
pubmed: 22161161
Obstet Gynecol. 1996 Jul;88(1):47-50
pubmed: 8684760
J Immunol. 2010 Sep 15;185(6):3190-8
pubmed: 20720200
Clin Infect Dis. 2020 Sep 12;71(6):1419-1426
pubmed: 31631221
Clin Vaccine Immunol. 2012 Mar;19(3):436-42
pubmed: 22219312
Am J Obstet Gynecol. 2003 Mar;188(3):719-26
pubmed: 12634647